The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1319-1326

  Sutton, Madeline ^a   Sternberg, Maya ^a   Koumans, Emilia H ^a   McQuillan, Geraldine ^b   Berman, Stuart ^a   Markowitz, Lauri ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; FEMALE GENITAL SYSTEM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POVERTY; PREVALENCE; PRIORITY JOURNAL; SEXUALITY; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; VAGINA DISCHARGE; VAGINA SMEAR; AFRICAN AMERICAN; AGE; ANIMAL; CAUCASIAN; GENETICS; HISPANIC; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARASITOLOGY; RISK FACTOR; SEXUAL BEHAVIOR; SOCIOECONOMICS; VAGINA;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; ANIMALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MEXICAN AMERICANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; VAGINA;

EID: 36049035725     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522532     Document Type: Article

References (40)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. Geneva: World Health Organization, 1995.
2. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26(4 Suppl):S2-7.
3. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspectives on Sexual and Reproductive Health 2004; 36:6-10.
4. Miller WC, Swygard H, Hobbs MM, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005;32: 593-8.
5. Cotch MF, Pastorek JG 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24: 353-60.
6. French JI, McGregor JA, Parker R. Readily treatable reproductive tract infections and preterm birth among black women. Am J Obstet Gynecol 2006; 194:1717-26; discussion 1726-7.
7. Sutton MY, Sternberg M, Nsuami M, Behets F, Nelson AM, St Louis ME. Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected Congolese women: prevalence, risk factors, and association with low birth weight. Am J Obstet Gynecol 1999; 181:656-62.
8. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
9. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177:167-74.
10. Guenthner PC, Secor WE, Dezzutti CS. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun 2005; 73:4155-60.
11. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
12. Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis 2004; 31:547-51.
13. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004; 36:11-9.
14. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002; 35:576-80.
15. Smith KS, Tabrizi SN, Fethers KA, Knox JB, Pearce C, Garland SM. Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas. International J STD AIDS 2005; 16:811-5.
16. Radonjic IV, Dzamic AM, Mitrovic SM, Arsic Arsenijevic VS, Popadic DM, Kranjcic Zec IF. Diagnosis of Trichomonas vaginalis infection: the sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol 2006; 126:116-20.
17. Brown HL, Fuller DD, Jasper LT, Davis TE, Wright JD. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol 2004; 12:17-21.
18. Lara-Torre E, Pinkerton JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolou smear. Am J Obstet Gynecol 2003; 188:354-6.
19. Brown HL, Fuller DA, Davis TE, Schwebke JR, Hillier SL. Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens. J Clin Microbiol 2001;39: 3197-9.
20. Workowski KA, Berman SM; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006; 55(RR-11):52-4 (erratum: 2006; 55:997).
21. National Health and Examination Survey. Data sets and related documentation. Available at: http://www.cdc.gov/nchs/about/major/nhanes/ datalink.htm. Accessed 29 November 2006.
22. National Health and Examination Survey. NHANES analytic guidelines. http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/ nhanes_analytic_guidelines_dec_2005.pdf. Accessed 22 January 2007.
23. Jordan JA, Lowery D, Trucco M. TaqMan-based detection of Trichomonas vaginalis DNA from female genital specimens. J Clin Microbiol 2001; 39:3819-22.
24. US Census Bureau. Civilian non-institutionalized population: national population estimates for the 2000s. 19 December 2005. Available at: http://www.census.gov/popest/national/asrh/2004_nat_ni.html. Accessed 22 January 2007.
25. Korn EL, Graubard BI. Analysis of health surveys. New York: Wiley, 1999.
26. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2000. Ann Intern Med 2007; 147:89-96.
27. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44:13-22.
28. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927-32.
29. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039-44.
30. Boyer CB, Shafer MA, Pollack LM, Canchola J, Moncada J, Schachter J. Sociodemographic markers and behavioral correlates of sexually transmitted infections in a nonclinical sample of adolescent and young adult women. J Infect Dis 2006; 194:307-15.
31. Swygard H, Miller WC, Kaydos-Daniels SC, et al. Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis 2004; 31: 659-64.
32. Crosby R, DiClemente RJ, Wingood GM, et al. Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex Transm Infect 2002; 78:360-4.
33. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005; 32:446-53.
34. Crucitti T, Van Dyck E, Tehe A, et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect 2003; 79:393-8.
35. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005; 43:684-7.
36. Garrow SC, Smith DW, Harnett GB. The diagnosis of chlamydia, gonorrhoea, and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice. Sex Transm Infect 2002; 78:278-81.
37. Lawing LF, Hedges SR, Schwebke JR. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 2000; 38:3585-8.
38. Kaydos SC, Swygard H, Wise SL, et al. Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol 2002; 40:89-95.
39. Van der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44:23-5.
40. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005. Vol. 17. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2006.